Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)
Autor: | M. Unsaín-Mancisidor, E. Garrote, B. Ferrer-Lorente, Jesús Ruiz-Contreras, Eduardo Doménech, S. Alfayate-Miguelez, M. Méndez-Hernández, M. San-Martín, L. Díaz-Munilla, B. Carazo-Gallego, J. Arístegui, F. Centeno Malfaz, J. Rodríguez-Suárez, B. Croche-Santander, M. Cotarelo, M. Illán-Ramos, J. T. Ramos-Amador, M. Mendizabal |
---|---|
Rok vydání: | 2022 |
Předmět: |
Rotavirus
Immunology medicine.disease_cause Rotavirus Infections health care resources Environmental health Health care medicine Humans Immunology and Allergy acute gastroenteritis Child Pharmacology business.industry Rotavirus Vaccines Infant Patient Acceptance of Health Care Hospitalization Cross-Sectional Studies Spain Child Preschool direct costs business Medical costs Resource utilization |
Zdroj: | HUMAN VACCINES & IMMUNOTHERAPEUTICS r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname Human Vaccines & Immunotherapeutics r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe |
ISSN: | 2164-554X 2164-5515 |
Popis: | Background: Rotavirus (RV) is the most common cause of severe gastroenteritis (GE) in infants and young children worldwide and is associated with a significant clinical and economic burden. The objective of this study was to analyze the characteristics, healthcare resource utilization and the direct medical costs related to RVGE hospitalizations.Methods: An observational, multicenter, cross-sectional study was conducted from June 2013 to May 2018 at the pediatric departments of 12 hospitals from different Spanish regions. Children under 5 years of age admitted to the hospital with a confirmed diagnosis of RVGE were selected. Data on clinical characteristics, healthcare resource use and costs were collected from patient records and hospital databases.Results: Most children hospitalized for RVGE did not have any previous medical condition or chronic disease. Forty-seven percent had previously visited the ER, 27% had visited a primary care pediatrician, and 15% had received pharmacological treatment prior to hospital admission due to an RVGE episode. The average length of a hospital stay for RVGE was 5.6 days, and the mean medical costs of RVGE hospitalizations per episode ranged from 3,940€ to 4,100€. The highest direct medical cost was due to the hospital stay.Conclusion: This study shows a high burden of health resource utilization and costs related to the management of cases of RVGE requiring hospitalization. RV vaccination with high coverage rates should be considered to minimize the clinical and economic impacts of this disease on the health care system. |
Databáze: | OpenAIRE |
Externí odkaz: |